From July 16 to 18, 2025, WHX Kuala Lumpur & WHX Labs Kuala Lumpur 2025 was held as scheduled. Exhibitors from more than 60 countries and regions and more than 10,000 participants participated in the event to explore more possibilities for the future development of the industry.
Empowering liver disease management with innovation
Eieling showcased its latest lineup of non-invasive liver health solutions to professionals from around the world, and won unanimous praise from customers with its cutting-edge technology and excellent performance. During the exhibition, InnoLion Technology demonstrated its innovative strength and technological accumulation, and conveyed its firm belief in helping Southeast Asia achieve new upgrades in early screening technology for liver disease.
As an outstanding representative of Hong Kong’s science and technology enterprises, Eieling Technology adheres to the concept of deep integration of industry, academia and research, continues to increase R&D investment, and through research and innovation, has achieved new possibilities of reducing costs and increasing efficiency in the field of liver disease diagnosis and treatment. At the booth, Eieling’s professional team actively communicated and discussed with industry experts and customers from Southeast Asia and around the world, introduced the innovations of the company’s products in detail, and answered questions raised by customers one by one. At the same time, we discussed in depth with visiting customers the innovation path and cooperation prospects, continued to promote the upgrading of liver disease early screening technology, and jointly built a regional health defense line.
Leading liver disease diagnosis and treatment to a new level with technology
Unlike traditional detection methods, Liverscan® creatively integrates real-time B-mode ultrasound-guided and transient elastic imaging technology. Real-time images assist operators in liver positioning, significantly reducing detection errors. The adjustable ROI frame effectively avoids non-liver parenchyma, and the diagnostic success rate can reach more than 90%. As an important tool for liver health assessment, Liverscan® can perform specific numerical assessments of liver fibrosis and fat content, accurately predict liver health, and facilitate medical staff to implement targeted disease management plans in the future. It saves medical care costs, thereby improving the overall management level of chronic liver disease and providing stronger protection for patients’ liver health.
At the same time, the cutting-edge liver fat detection solution FattaLab® also attracted much attention. The system is a perfect combination of lightweight and precision, bringing a breakthrough upgrade to the liver detection ecosystem. With automatic, efficient and accurate detection technology, it redefines the fatty liver detection process, promotes a major leap from the 2.0 era to the 3.0 era of liver health detection, and opens a new chapter in liver health detection.
Promoting technological development to new heights with a global vision
As an innovator in accurate liver disease detection, Eieling continues to expand the boundaries of innovative technology, committed to providing accurate and efficient liver health solutions, and providing strong support for improving the health of liver disease patients around the world. Inspire Technology will take practical actions to promote the innovation and upgrading of precision medicine in Southeast Asia and continue to contribute more to the treatment of liver diseases.